BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1988614)

  • 1. Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.
    Van den Abbeele AD; Aaronson RA; Daher S; Taube RA; Adelstein SJ; Kassis AI
    J Nucl Med; 1991 Jan; 32(1):116-22. PubMed ID: 1988614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advantage of protecting the antigen-binding site during antibody labeling.
    Krohn KA; Eary JF
    J Nucl Med; 1991 Jan; 32(1):122-3. PubMed ID: 1988615
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigen protection of monoclonal antibodies undergoing labelling.
    Ramjeesingh M; Zywulko M; Rothstein A; Whyte R; Shami EY
    J Immunol Methods; 1990 Oct; 133(2):159-67. PubMed ID: 2230135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
    Zalutsky MR; Narula AS
    Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay.
    Wagener C; Clark BR; Rickard KJ; Shively JE
    J Immunol; 1983 May; 130(5):2302-7. PubMed ID: 6187848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bond-targeted radiolabeling: tumor specificity of a streptavidin-biotinylated monoclonal antibody complex.
    del Rosario RB; Wahl RL
    Cancer Res; 1990 Feb; 50(3 Suppl):804s-808s. PubMed ID: 2297728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I-rituximab: relationship between immunoreactivity and specific activity.
    Schaffland AO; Buchegger F; Kosinski M; Antonescu C; Paschoud C; Grannavel C; Pellikka R; Delaloye AB
    J Nucl Med; 2004 Oct; 45(10):1784-90. PubMed ID: 15471849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for radiolabelling of monoclonal antibodies.
    Tolmachev V; Orlova A; Andersson K
    Methods Mol Biol; 2014; 1060():309-30. PubMed ID: 24037848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple remote system for the high-level radioiodination of monoclonal antibodies.
    Weadock KS; Anderson LL; Kassis AI
    J Nucl Med Allied Sci; 1989; 33(1):37-41. PubMed ID: 2746366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
    Beyers M; Aspinall S; Conradie JD; Fourie PJ
    Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111.
    Paik CH; Hong JJ; Ebbert MA; Heald SC; Reba RC; Eckelman WC
    J Nucl Med; 1985 May; 26(5):482-7. PubMed ID: 3989604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. I. Analysis of the mechanism of binding.
    Dower SK; Ozato K; Segal DM
    J Immunol; 1984 Feb; 132(2):751-8. PubMed ID: 6690617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.
    Lemonnier FA; Le Bouteiller PP; Olive D; Malissen B; Mishal Z; Layet C; Dubreuil J; Caillol DH; Kourilsky FM; Jordan BR
    J Immunol; 1984 Mar; 132(3):1176-82. PubMed ID: 6198381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotype switch variant anti-idiotype monoclonal antibodies: comparative radiolabeling and in vitro binding.
    Wahl RL; Wissing JR; Kaminski MS
    J Nucl Med; 1989 Feb; 30(2):227-32. PubMed ID: 2738651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.
    Gridley DS; Ewart KL; Cao JD; Stickney DR
    Cancer Res; 1991 Mar; 51(5):1515-20. PubMed ID: 1997192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
    Kutok JL; Coller BS
    Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiolocalization of bovine lymphosarcoma cells in athymic mice, using a monoclonal antibody against tumor-associated antigens.
    Aida Y; Ochiai K; Ito K; Onuma M; Fujimori F; Fujimoto Y; Izawa H
    Am J Vet Res; 1987 Aug; 48(8):1181-6. PubMed ID: 2820277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
    Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Nicoletti C
    Exp Mol Pathol; 1995 Apr; 62(2):99-108. PubMed ID: 8549700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of monoclonal antibody delivery via the lymphatics: the dose dependence.
    Steller MA; Parker RJ; Covell DG; Holton OD; Keenan AM; Sieber SM; Weinstein JN
    Cancer Res; 1986 Apr; 46(4 Pt 1):1830-4. PubMed ID: 3948166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.